News & Perspective

Aug 15, 2019

Aug 15, 2019

News Scan for Aug 15, 2019

More DRC Ebola cases
Australian flu activity analysis
Rotavirus vaccine impact
Lyme serologic testing

Jun 05, 2019

Jun 05, 2019

News Scan for Jun 05, 2019

Hospital superbugs in Tuscany
Universal flu vaccine trial
Cholera vaccine storage

Sep 12, 2018

Sep 12, 2018

News Scan for Sep 12, 2018

Nigeria assist for UK monkeypox
Measles and public health cuts
Global Fund disease progress
Seqirus cell-based flu vaccine

Jul 19, 2018

Jul 19, 2018

News Scan for Jul 19, 2018

Low UK flu vaccine protection
FDA mulls sole-source drug supply
Evaluating Ebola vaccine
Ebola medical treatments
HPV vaccine in boys, men

Jul 06, 2018

Jul 06, 2018

News Scan for Jul 06, 2018

Polio in Afghanistan, Somalia
Pregnancy and flu
CDC reports more Cyclospora illnesses
Frozen veggie Listeria outbreak in Europe

May 14, 2018

May 14, 2018

News Scan for May 14, 2018

Expanded use of Zika test
Universal flu vaccine award

Jan 12, 2018

Jan 12, 2018

News Scan for Jan 12, 2018

H7N9 death in China
Fluarix Quad for babies
Avian flu outbreaks
Vaccine-linked polio in DRC

Oct 12, 2016

Oct 12, 2016

News Scan for Oct 12, 2016

C diff in dogs
MERS risks
Migrant TB screening
4-strain Flublok OK'd
Salmonella in eggs

Nov 25, 2015

Nov 25, 2015

Flu Scan for Nov 25, 2015

Adjuvanted flu vaccine
UK flu deaths last season
H5N1 in France, Vietnam

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»